Used in pharmaceutical research as a potent and selective inhibitor of fatty acid amide hydrolase (FAAH), an enzyme responsible for the breakdown of endocannabinoids like anandamide. By inhibiting FAAH, this compound increases endocannabinoid levels in the brain, leading to potential therapeutic effects in pain management, anxiety, and inflammation without the psychoactive effects associated with cannabinoid receptor agonists. It serves as a key tool compound in neuroscience studies exploring the endocannabinoid system and has been investigated for its role in developing treatments for neurodegenerative diseases and mood disorders.